initi coverag unit state go sg websit
scent fundament valu
upsid tp
initi coverag buy rate tp rank number
two highly-defens flavour fragranc sector despit similar
profil stock under-perform peer sinc acquisit
frutarom may wide view overvalu integr
litig issu ad pressur top- bottom-lin trend close
turn point restructur underway
issu
address see fundament valu opportun
fundament valu frutarom ye may paid
ev/ebitda israel natur ingredi specialist frutarom market perceiv
overvalu fear compound relat profit warn aug subsequ
under-perform vs european peer left frutarom implicitli trade
think harsh acknowledg month
still integr risk see frutarom excel strateg fit expand iff product
offer seven categori strong presenc adjac natur
small- mid-siz client segment help catch peer term growth
under-perform past decad note also deal emul earlier
move symris paid top come synergi
cost save target compani
current integr pain unusu timing-wis frutarom deal remind
us givaudan acquisit quest late close peak prolong
econom cycl phase signific raw materi inflat subsequ
took givaudan three year overcom growth weak sale de-synergi
five year return pre-acquisit profit thereaft givaudan
experienc long period strong growth except cash flow gener
interestingli share price start recov well turnaround econom
metric iff frutarom deal fulli compar quest judg
post-acquisit challeng similar face givn henc
optimist overcom emerg strengthen
integr process address persist input cost inflat
valuat ev/ebitda trade discount peer sotp-
base valuat struck discount peer ev price-to-earnings reflect iff
histor slower top line growth higher earn volatil issu frutarom
help eas time input dp yield impli tsr buy
societ general sg seek busi compani cover research report result investor awar
sg may conflict interest could affect object report investor consid report singl factor
make invest decis pleas appendix end report analyst certif
new power hous
close gap fast-grow adjac indi brand privat label specialist
risk tabl
see valu frutarom
signific acquisit frequent result temporari headwind
ambiti synergi cost save target
iff legaci busi margin alreadi close turn point
top bottom line growth set acceler
valuat discount us compani rare
european peer close frutarom integr
frutarom pay medium/long term
parallel frutarom quest acquisit
overview flavour fragranc attract nich offer defens profit growth
although us-bas compar european peer term busi profil
stock trade discount ev earn multipl shown fear
overpaid israel natur ingredi specialist frutarom back may
compound recent integration-rel profit warn august
announc briberi investig frutarom oper russia/ukrain
sale forc investor exit could expos on-going
investig think harsh especi expect significantli acceler
defens top- bottom-lin growth medium term back frutarom
sale target non-discretionari food cosmet end market expect
grow even advers econom environ scent tast top
criteria influenc consum buy decis account end-
product cost good sold cog peer gener stabl normalis
sale cagr ebitda margin attract cash convers long
term moreov cater wide rang brand risk over-exposur singl
client segment low
concern frutarom overdon opportun outweigh risk
ye overpaid isra frutarom follow
under-perform vs peer sinc deal announc estim market
implicitli valu frutarom substanti discount purchas price see
attract valu opportun
gener unhelp headlin think on-going briberi investig
materi impact compani overal oper valu asset
spotlight russia/ukrain account sale initi impact drop
comp base earli
otherwis frutarom look like excel strateg fit expand compani
portfolio fast-grow adjac like savouri solut natur food protect
well ad exposur import regional/loc brand privat label produc
manag target integr synergi addit cost save
combin sale also see financi leverag fall
ev/ebitda
sure integr frutarom aggress acquir
purchas like difficult task could integr issu
howev look past deal sector quest/givaudan particular see
page think prove manag
shown matrix conclud opportun outweigh risk
risk vs opportun benefit outweigh risk still risk especi link frutarom integr
consensu compil sg cross asset research/equ
opportunitiesriskstechnical sell due briberi investig overpaid frutaromsignific valuat discount peersunresolv briberi investig integr risk alreadi price inintegr frutarom still earli stagesignific self help risk integr setbackshigh exposur high growth market pocket pend acceler top bottom line growthlow acquisit adj definit
new power hous
close gap fast-grow adjac indi brand
initi coverag buy rate target price ev/ebitda
trade discount peer sotp-bas valuat struck
discount peer ev price-to-earnings reflect iff histor slower top line growth
higher earn volatil issu frutarom help eas time input dp
second-largest fragranc flavour compani global per sale
manag new york citi global presenc via product plant
centr sale offic
oper three vertic scent tast nutrit ingredi split
scent account group sale ebit target beauti industri
tast gener sale ebit target food beverag produc
nutrit ingredi gener group sale includ frutarom
busi frutarom creat manufactur naturals-focus suit flavour
compound specialti fine ingredi larg target small local region
custom frutarom seek capitalis consum health well focu deliv
growth offer natur flavour product combin solut creat natur colour
natur function food ingredi promot health benefit extend shelf life
base histor focu major frutarom raw materi product come
natur sourc
frutarom enhanc iff portfolio new fast-grow adjac fast-grow region white label produc
thank acquisit frutarom late significantli grown presenc
faster-grow indi brand frequent refer region local produc
fast-grow complimentari adjac natur colour antioxid food
preserv nutraceut ingredi infant formula protein elderli nutrit
also expand core product line savouri solut aim meat fish
industri citru natur flavour specialti ingredi well new cosmet
frutarom provid greater access attract adjac
think blueprint compani expans faster-grow market pocket
germani symris significantli outperform peer thank earli portfolio
exposur fast-grow indi brand sale
exposur fast-grow adjac market sale
emerg market exposur sale
product categori sale
symris product categori sale
givaudan product categori sale
posit weak due lack scale balanc sheet strength symris
chose expand portfolio beyond core keep pace bigger much stronger
peer expans low multipl natur nutrit cosmet ingredi via diana
also ad exposur pet food pinova result superior
growth past decad
follow frutarom acquisit last year significantli narrow gap symris
term sale exposur natur nutrit cosmet see chart
manag guid currency-neutr top-lin compound-annual-growth-rate long term
broken organ growth driven cross-sel integr solut
frutarom via expect gener rang sale
manag also ambiti de-lever target net debt/ebitda
target dividend yield
iff revenu growth target compar givaudan organ
symris inc term growth manag posit
compani ahead givaudan line symris
term profit givaudan guid cash gener sale
margin target vice versa symris target ebitda margin cash
target dividend wise givaudan symris implicitli aim least stabl pay out
follow unpreced input cost inflat driven unusu
accumul plant incidents/shutdown basf citral menthol line also number
import supplier plant asia sector ebitda margin drop
two year although take time increas sell prices/reformul recip suppli
crucial raw materi recent start stabilis believ profit
 compani alreadi turn point
inde see indic input cost price start stabilis basf
citral/menthol suppli close normal vanilla suppli think input price
start normalis addit sector final manag pass higher cost
onto custom testifi price increas confid statement variou
compani henc expect profit improv materi bottom-lin growth
short think clearli sweet spot also reap integr
synergi cost save along boost thank
normalis capital-expenditure sale current next year
 segment offer defens growth characterist sale relat non-
discretionari fast-mov consum good food cosmet typic
account end product cog fine fragranc
time tast smell key buy decis
 supplier cater multi-national regional/loc develop emerg market
brand white label produc risk over-exposur single/few major client
lumpi limit justifi premium vs multi-national stock view
flavour fragranc account neglig part end product cost among major driver
given defens characterist combin like acceler bottom-lin growth
think sector defend rel high valuat multipl valu compani
sop basi input ev/ebitda price-to-earnings multipl adjust price-to-earnings multipl
amortis acquisit see chart assum stabil go forward
risk tabl
month frutarom integr process still earli stage like
run bump road said think financi market overli
cautiou frutarom acquisit particular moreov along strateg
advantag frutarom deal well advertis compani think
risk aris integr emerg market compani aggress acquir
asset prior acquir tabl think time
share price perform index date significantli under-perform follow
announc frutarom deal announc briberi
investig think investor liquid stake could
expos briberi investig
along uninspir result frutarom underli sale yoy reduc
guidanc adj ep target report close august manag
announc face briberi investig integr process
discov improp payment made ukrain russia oper
frutarom call manag stress improp payment longer
made amount involv materi less sale
combin group
think handl briberi incid profession firstli manag
voluntarili went public soon becam awar issu secondli took outsid
legal account advic find proactiv transpar approach reassur
also note mani investor expos unresolv briberi
investig consequ liquid posit follow announc
think technic least explain share price collaps day follow
result token think plausibl share price gap
open august could close quickli briberi issu
resolv although exact time unknown think least reassur could
come novemb along result
see valu frutarom
iff move acquir frutarom certainli got bumpi start think givaudan
acquisit integr quest tell encourag tale
frutarom quest certainli fulli compar term activ integr
challeng differ analysi deal thrown interest
firstli surpris current slowdown organ growth frutarom
underli pre-acquisit mid-single-digit run-rat averag accord
difficult verifi given isra group made frequent acquisit organ growth
flat yoy think revers reflect internalis
extern sale client overlap case frutarom competitor stop buy citru raw
materi citrasourc acquir current unfavour market
environ pocket weak natur colour pass decreas input
cost weigh organ growth russia/ukrain briberi investig hamper demand
region compound on-going headwind strong input cost inflat
view none pressur game-chang
signific acquisit frequent result temporari
secondli think histori iff side acquir quest late around peak
cycl period rise margin pressur due input cost inflat givaudan
found weak spot year nonetheless quest becom true long-term
success stori givaudan point financi market start look beyond
integr market challeng earli turn givaudan share price perform
posit well group financi metric recov see similar scope earli
rebound iff share price anticip success frutarom integr process
said given frutarom aggress acquisit strategi recent year integr
process still like rais unexpect challeng howev think
materi issu frutarom and/or commerci process would alreadi
made public inde way manag handl briberi issu
russia ukrain indic us would shi away integr challeng
givaudan quest acquisit combin raw materi price inflat result disappoint share price
perform sale de-synergi integr setback margin pressur put stock signific pressur
iff share price drop acquisit announc level due integr headwind briberi case russia
ukrain result profit warn august think game-chang see current share price
attract entri opportun
share price chf per announc quest acqusit ev/ebitda feb mandatori convert slow organ growth yoy organ growth revers posit ebitdamargin trend margin declin yoy cost inflat start weigh share price per sharemay frutarom acquisitionfor ev/ebitdasept capit increas frutarom profit warn briberi investig
ambiti synergi cost save target
prior acquir frutarom vigor integr acquisit inde
frutarom profil like hold compani manag grow portfolio fast-
grow independ satellit compani acquir compani like
associ rather subsidiari
ad frutarom oper manufactur facil creativ centr
applic laboratori differ countri frutarom gain addit
manufactur facil addit d/applic laboratori global includ
mani countri alreadi oper region overlap fact
frutarom significantli higher number product unit laboratori despit
less half size indic signific scope rationalis
frutarom went aggress acquisit spree
think manag plan fulli integr frutarom legaci acquisit
network process certainli come opportun signific cost could
taken addit sale synergi like tap current manag guid
increment sale impli compound-annual-growth-rate
howev entail heavi legwork involv plant closur identifi plant
closur initi redund henc challeng look
manag guid integr save run rate less
frutarom sale addit across iff legaci oper
sale may look ambiti seem justifi
given frutarom vast product laboratori network geograph overlap
note follow acquisit quest givaudan announc deliv
estim synergi amount quest sale
iff legaci busi margin alreadi close turn point
see major posit differ givaudan-quest iff-frutarom deal
input cost inflat relat recur temporari margin pressur start build
integr quest time around input cost inflat even stronger
back amplifi string unplan supplier plant shutdown basf
chines indian supplier began therefor conclud
alreadi peak alreadi see sign start eas almost
compani guid low- mid-single-digit input cost inflat would
good
due delay pass-through input cost inflat price increas take time due
contract time need negoti and/or reformul recip iff ebitda margin
contract howev histor industri
consist prove abl restor margin via price increas think time
differ least almost entir industri flag margin improv
notabl
said still face neg base effect due loss busi
citrasourc weaker growth momentum russia ukrain improp payment client
termin margin dilut relat frutarom howev frutarom
close octob posit base effect kick
exposur non-discretionari structur grow nutrit
cosmet end-market view fragranc flavour defens sector
financi crisi saw two consecut quarter neg underli growth
still deliv posit organ growth annualis basi even trough year
subsequ worst-cas recess scenario includ underli top-lin
growth even meaning bottom-lin growth input cost tend weaken
recess integr benefit cost save effort lend support
also see fresh growth opportun separ sector report also publish today
explor potenti aris recent success plant-bas proteins/meat
short think sweet spot continu benefit new structur
growth trend top exist health well natur sustain theme
exampl recent success plant-bas patti produc beyond
meat imposs food creat new growth opportun contrast
fresh meat virtual plant-bas patti use natur flavour given current urbanis
trend one hand desir healthier lifestyl global see
plenti innov growth opportun compani
top bottom line growth set acceler
chart show histor struggl deliv top-lin target
keep peer sale earn also compar volatil
think mainli reflect lack diversif adjac high-growth market
start expand adjac market via bolt-on acquisit
absent market almost decad also relat iff histor lack
exposur fast-grow region local white-label produc limit natur
organ growth volatil compar peer
ad frutarom portfolio significantli strengthen presenc
exact dynam growth segment henc view sale de-synergi weak
isol market pocket natur colour russian/ukrain overcom start
outperform peer
report sale growth givaudan hit fx effect symris benefit
diana acquisit set benefit frutarom integr
valuat discount us compani rare
rare exampl us compani trade valuat discount european peer
stock current trade discount givaudan symris ev
see sever explan discount
past struggl keep pace peer term top-lin growth
coupl rel high top- bottom-lin volatil
taken rel technical/chem approach busi past
communication-wis symris givaudan croda mainli focus
innov
last
reposit sweet spot consum good sector consequ
earn valuat premium vs consum good compani
european special ingredi compani grow faster profit
custom thank broad custom base product
portfolio includ exposur smaller indi brand local region player
emerg market etc short shown littl lumpi regard
clients/brand overreli singl client/seg
think integr frutarom progress catch even outperform
european peer term growth profit thu narrow discount
weak profil us-term may anoth headwind
note anoth specif us stock market may often simpli overlook
north american investor compar small compani big diversifi
market place lack critic number domest high-qual peer contrast
europ wider small mid-cap special ingredi segment signific
includ croda symris givaudan kerri dsm chr hansen novozym addit
bigger group small- mid-cap special chemic name offer defens
characterist combin high return henc premium valuat includ
like fuch petrolub victrex em chemi
benchmark european peer test pass
think iff busi model good match european peer especi post-
frutarom saw close gap symris term portfolio diversif fast-
grow adjac exposur fast-grow region local player
signific acquisit grown market size current frutarom market
cap around half henc visibl perspect see
uniqu opportun narrow even entir close valuat gap vs european
peer back success integr frutarom next two three year
broad peer group valuat point fair valu per share
european peer close frutarom integr
croda best single-stock benchmark
use stock-market comparison valu due compar high top-and
bottom-lin volatil past compar compani appli
discount shown tabl result valu less line
croda uk lead special ingredi compani supplier high-qual cosmet
consum ingredi gener impress margin catch croda
also exposur volatil special chemic best match
term current risk/volatil profil
iff number challeng deciph
make extens non-gaap adjust ebitda ebit ep free cash flow net
debt/ebitda result high number metric altern although adjust
meant improv visibl underli busi make compar
european peer also creat seriou challeng term consist number
valuat consensu
asid strip non-recur cost relat restructur integr major
acquisit adj ebit adj ep also exclud amortis relat
histor acquisit moreov net debt/ebitda calcul base definit
agre lender disclos ident adjust
appli adjust ebitda ebitda us-gaap account adjust ep
besid absolut sale number underli sale growth rate adjust ep ex
amortis profit indic provid market annual basi
addit adjust net debt/ebitda defin lender /sale
anoth non-gaap metric featur manag mid-term guidanc
net debt/ebitda guidanc base non-gaap metric despit disclosur
adjust criteria iff websit criteria fulli transpar
base combin result net debt adjust ebitda non-gaap metric non-gaap disclosur ir iff com
given european compani partial follow iff practic recent
disclos acquisition-rel amortis calcul compar adjust
ep number ex amortis shown overview tabl page howev
multipl way account amortis acquir intang asset recip
brand patent client list includ acquisition-rel amortis adjust
frutarom pay medium/long term
parallel frutarom quest acquisit
givaudan pick quest weak
uk compani quest acquir givaudan novemb
ev/ebitda quest part diversifi chemic group icl tradit player
presenc flavour fragranc henc signific client overlap
givaudan acquir quest encount signific product problem suppli
issu subsequ client loss time acquisit quest gener
ebitda margin may seem overly-demand today
perspect ev/ebitda acquisit multipl compar high time
especi consid quest compar low profit damag reput
nevertheless givaudan clearli seiz opportun buy quest moment weak
success turn around platform thereaft
time acquisit givaudan guid integr synergi
aggress quest sale target frutarom sale plu cost save
level worth sale although took longer expect givaudan deliv
target
bought frutarom latter long acquisit streak
israel frutarom unlik quest mainli flavour nutrit ingredi compani
limit presenc fragranc
frutarom segment trade market segment margin dilut
acquir frutarom period strong growth fuell mainli
acquisit pa frutarom organ growth rel close iff
profit ebitda margin portfolio highli complementari limit
frutarom histor sale ebitda net incom develop
given frutarom growth profit less line peer group
averag consid associ portfolio risk littl visibl level integr
acquir busi ev/ebitda multipl paid frutarom pre-synergi
look high strateg fit look good potenti top-
bottom-lin synergi signific
frutarom well posit fast-grow region local brand sale
privat label produc sale bring signific exposur emerg
market strong focu central eastern europ high proport
natural/clean label solut sale combin group key
iff long-term growth potenti highli benefici profil view
frutarom enhanc iff portfolio new fast-grow adjac fast-grow region white label produc
frutarom strong posit savouri solut process meat fish readi
meal sector think strong behind givaudan market skill set
also enhanc prospect becom prefer partner fast-grow
second-gener plant-bas patti market think beyond meat frutarom also
exposur natur colour paprika natur anti-oxid rosemari algae-bas
cosmet ingredi taura busi also strengthen iff exposur dri
fruit/clean label fruit bar segment iff powderpur brand overal frutarom iff
product offer grown categori
acquir may frutarom made strateg
acquisit sinc earli includ eight one
frutarom acquisit strategi focus expand sale market share north
america emerg market increas share flavour includ establish
lead posit savouri tast solut broaden deepen portfolio natur
frutarom target lead posit savouri solut
head sustain research
summaris croda givaudan symris manag environment
social govern esg aspect nutshel appli proprietari esg rate see
right margin well rate good understand strong
manag key esg issu face note good score
support absenc major esg-rel controversi four compani
board independ stand independ board
member declar independ givaudan symris croda respect
independ board director
separ board chair ceo role apart compani separ
chair ceo role
independ chair croda independ chair wherea
givaudan symris
capit structur stock held winder invest ltd invest
vehicl indirectli own tetra pak famili howev far awar
long-term passiv invest none compani dual class share everi share
give right one vote equal dividend
success plan none compani disclos success plan ceo
chair
esg govern term esg govern fare well apart givaudan
board level committe deal esg topic three compani
manag committe specif focus esg
product specialti chemic may involv toxic substanc compani
requir adher specif employe health safeti standard manufactur
includ regul address process safeti chemic storag focu
prevent acut health safeti hazard
safeti manag system croda appear best class among peer
group use wherea givaudan lag compar croda givaudan appear lack
regular health train programm employe emerg prepared procedur
audit conduct least everi three year appar lack clear target reduc
incid occup health safeti perform remain broadli flat total
record injuri rate employe injur per hour work
symris appear lack procedur hazard identif risk assess
safeti certif croda appear best class among
peer group use wherea givaudan lag croda manufactur site
extern certifi ohsa standard wherea abl find
inform extern certif givaudan facil
methodolog esg rate
sustain product servic sector acknowledg esg could seen
opportun rather risk rare mention discuss earlier report
identifi two trend promis impact flavour fragranc
industri compani increasingli base product natur raw materi
raw materi natur product compani sell natur flavour
ingredi contribut reduc use resourc ghg emiss help
ghg reduct programme/carbon intens four compani fare well compar
rest overal market two metric
renew energi use improv reach less
croda primari energi use come renew energi wherea peer
hazard product lag peer point rel speak offer product
import human health environment concern galaxolid
methoxycinnam methyloxiran dep howev product account less
total revenu
valu minor
valu financi invest
depreci amortis
chang work capit
flow oper activ
flow invest activ
flow financ activ
net chang cash result cf
intang
share basic year end/outstand
share price average hist yr current
report complet sep cet
follow name research analyst herebi certifi certifi view express research report accur reflect
person view subject secur issuer ii part compens
relat directli indirectli specif recommend view express report thoma swoboda
analyst author research employ sg affili locat includ limit pari london new york
hong kong tokyo bangalor frankfurt madrid milan geneva seoul warsaw moscow
valu per share base sotp model appli valuat discount european peer group ev
earn multipl due histor slower top line growth higher earn volatil
downsid materi setback integr frutarom lead sustain turnov profit growth loss intang asset
write off potenti impact tp sharp input cost inflat histor weak short-term price power price increas take
month potenti impact tp return oper issu like malodour issu asia fda mandat product recal
potenti impact tp
equiti rate dispers relationship
updat
sg equiti research rate month period
buy absolut total sharehold return forecast
month period
hold absolut total sharehold return forecast
month period
sell absolut total sharehold return forecast
plu forecast cash dividend incom includ incom
special dividend paid month period rate
determin rang describ time
initi coverag chang rate subject limit
manag discret time rate may fall outsid
rang market price movement and/or
short term volatil trade pattern interim deviat
specifi rang permit becom subject
review research manag
sector weight definit month period
sector weight assign sg equiti research
strategist distinct separ sg equiti research
analyst rate base relev
overweight sector expect outperform relev broad
market benchmark next month
neutral sector expect perform in-lin relev
broad market benchmark next month
underweight sector expect under-perform relev
broad market benchmark next month
prefer least prefer stock select
cover analyst base individu analyst coverag
univers sg equiti research strategist
price inform includ report market close unless otherwis state
disclaim sourc inform exclus properti morgan stanley capit intern inc without
prior written permiss inform intellectu properti may reproduc redissemin
use creat financi product includ indic inform provid basi user assum entir
risk use made inform affili third parti involv relat comput compil
inform herebi expressli disclaim warranti origin accuraci complet merchant fit particular
purpos respect inform without limit forego event shall affili
third parti involv relat comput compil inform liabil damag kind morgan
stanley capit intern index servic mark affili similar languag may
provid approv advanc
